Complex formation between cyclodextrins and 1 ,d-dihydroxyanthraquinone in buffer solution has been investigated using absorption, its second derivative (D'), and fluorescence spectroscopy. The results showed that whereas the self-association process was found for 1,8-dihydroxyanthraquinone alone, t
Inclusion complexation of prostaglandin f2α with γ-Cyclodextrin in solution and solid phases
✍ Scribed by Kaneto Uekama; Fumitoshi Hirayama; Akihiko Fujise; Masaki Otagiri; Kohji Inaba; Hazime Saitô
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- English
- Weight
- 342 KB
- Volume
- 73
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
✦ Synopsis
A solid complex of prostaglandin F h (dinoprost) with y-cyclodextrin in a molar ratio of 1:1 was obtained on the basis of the Bs-type phase solubility diagram. The mode of interaction in the solid state was studied by powder X-ray diffractometry, thermal analysis, and carbon-13 cross polarization/magic angle spinning nuclear magnetic resonance (W-CP/MAS-NMR) spectrometry. The X-ray diffraction and NMR data suggested that prostaglandin Fzu is included in the cylindrical channels formed by coaxial alignment of y-cyclodextrin molecules to give a channel type structure. Dissolution and thermal behaviors of the prostaglandin F*,-y-cyclodextrin complex were examined and compared with the drug itself. The result indicated that the y-cyclodextrin complex may have great utility as a rapidly dissolving form of prostaglandin F s ~ with improved thermal stability.
Keyphrases Prostaglandin Fa,-inclusion complex with y-cyclodextrin, solution and solid phases, solubility, dissolution behavior 0 y-Cyclodextrin-inclusion complex with prostaglandin Fk, solution and solid phases, solubility, dissolution behavior 0 Solubility-prostaglandin Fk-y-cyclodextrin inclusion complex, dissolution behavior 0 Dissolution-prostaglandin Fz,-y -cyclodextrin complex, solubility
📜 SIMILAR VOLUMES
The inclusion complex formation of alpha-cyclodextrin (alpha-CyD), beta-cyclodextrin (beta-CyD), and 2-hydroxylpropyl-beta-cyclodextrin (HP-beta-CyD) with an angiotensin converting enzyme inhibitor, captopril, in aqueous solution was studied by (1)H- and (13)C-nuclear magnetic resonance spectroscopi
Inclusion complexation between celecoxib, a specific cyclooxygenase II inhibitor, and beta-cyclodextrin (b-CD) was studied in solution and solid state. Drug cyclodextrin complexes were prepared by spray drying while physical mixtures were obtained by simple blending. Inclusion complexes were charact